Glabridin protects paraoxonase 1 from linoleic acid hydroperoxide inhibition via specific interaction: A fluorescence-quenching study

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 14, 2012, Pages 3679-3685

  Atrahimovich, Dana ^a,b   Vaya, Jacob ^a,b   Tavori, Hagai ^a   Khatib, Soliman ^a,b  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b TEL HAI COLLEGE   (Israel)

Author keywords

antioxidant; flavonoid; fluorescence; glabridin; HDL; paraoxonase 1

Indexed keywords

ANTIOXIDANT; FLAVONOID; GLABRIDIN; HDL; PARAOXONASE 1;

AGENTS; AMINO ACIDS; FLUORESCENCE; KETONES; LINOLEIC ACID; QUENCHING;

ENZYME INHIBITION;

ARYLDIALKYLPHOSPHATASE; ENZYME INHIBITOR; GLABRIDIN; ISOFLAVONE DERIVATIVE; LINOLEIC ACID; LINOLEIC ACID HYDROPEROXIDE; LIPID PEROXIDE; PHENOL DERIVATIVE; RECOMBINANT PROTEIN;

ARTICLE; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; GLYCYRRHIZA; METABOLISM; PLANT ROOT; SPECTROFLUOROMETRY; THERMODYNAMICS;

ARYLDIALKYLPHOSPHATASE; BINDING SITES; ENZYME INHIBITORS; GLYCYRRHIZA; ISOFLAVONES; LINOLEIC ACIDS; LIPID PEROXIDES; PHENOLS; PLANT ROOTS; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS;

GLYCYRRHIZA;

EID: 84859618901     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf2046009     Document Type: Article

References (43)

1. Tavori, H.; Khatib, S.; Aviram, M.; Vaya, J. Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity Bioorg. Med. Chem. 2008, 16 (15) 7504-9
2. Mackness, B.; Quarck, R.; Verreth, W.; Mackness, M; Holvoet, P. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome Arterioscler., Thromb., Vasc. Biol. 2006, 26 (7) 1545-50
3. Rosenblat, M.; Vaya, J.; Shih, D.; Aviram, M. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine Atherosclerosis 2005, 179 (1) 69-77
4. Shih, D. M.; Welch, C.; Lusis, A. J. New insights into atherosclerosis from studies with mouse models Mol. Med. Today 1995, 1 (8) 364-72
5. Xiao, J.; Cao, H.; Wang, Y.; Zhao, J.; Wei, X. Glycosylation of dietary flavonoids decreases the affinities for plasma protein J. Agric. Food Chem. 2009, 57 (15) 6642-8
6. Duthie, G. G.; Duthie, S. J.; Kyle, J. A. Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants Nutr. Res. Rev. 2000, 13 (1) 79-106
7. Ramos, S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways Mol. Nutr. Food Res. 2008, 52 (5) 507-26
8. Hou, D. X.; Kumamoto, T. Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling Antioxid. Redox Signaling 2009, 13 (5) 691-719
9. Virgili, F.; Marino, M. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity Free Radical Biol. Med. 2008, 45 (9) 1205-16
10. Williams, R. J.; Spencer, J. P.; Rice-Evans, C. Flavonoids: antioxidants or signalling molecules? Free Radical Biol. Med. 2004, 36 (7) 838-49
11. Hodek, P.; Trefil, P.; Stiborova, M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450 Chem.-Biol. Interact. 2002, 139 (1) 1-21
12. Spencer, J. P.; Schroeter, H.; Crossthwaithe, A. J.; Kuhnle, G.; Williams, R. J.; Rice-Evans, C. Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts Free Radical Biol. Med. 2001, 31 (9) 1139-46
13. Abd El Mohsen, M. M.; Kuhnle, G.; Rechner, A. R.; Schroeter, H.; Rose, S.; Jenner, P.; Rice-Evans, C. A. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion Free Radical Biol. Med. 2002, 33 (12) 1693-702
14. Vaya, J.; Tavori, H.; Khatib, S. Structure-activity relationships of flavonoids Curr. Org. Chem. 2011, 15 (15) 2641-2657
15. Spencer, J. P.; Rice-Evans, C.; Williams, R. J. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability J. Biol. Chem. 2003, 278 (37) 34783-93
16. Huang, Z.; Fang, F.; Wang, J.; Wong, C. W. Structural activity relationship of flavonoids with estrogen-related receptor gamma FEBS Lett. 2010, 584 (1) 22-6
17. Somjen, D.; Knoll, E.; Vaya, J.; Stern, N.; Tamir, S. Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo J. Steroid Biochem. Mol. Biol. 2004, 91 (3) 147-55
18. Kanakis, C. D.; Tarantilis, P. A.; Polissiou, M. G.; Diamantoglou, S.; Tajmir-Riahi, H. A. Antioxidant flavonoids bind human serum albumin J. Mol. Struct. 2006, 798, 69-74
19. Papadopoulou, A.; Green, R. J.; Frazier, R. A. Interaction of flavonoids with bovine serum albumin: a fluorescence quenching study J. Agric. Food Chem. 2005, 53 (1) 158-63
20. Sun, Y.; Zhang, H.; Sun, Y.; Zhang, Y.; Liu, H.; Cheng, J.; Bi, S; Zhang, H. Study of interaction between protein and main active components in Citrus aurantium L. by optical spectroscopy J. Lumin. 2010, 130, 270-279
21. Tavori, H.; Aviram, M.; Khatib, S.; Musa, R.; Mannheim, D.; Karmeli, R.; Vaya, J. Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284 Free Radical Biol. Med. 2010, 50 (1) 148-56
22. Vaya, J.; Belinky, P. A.; Aviram, M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation Free Radical Biol. Med. 1997, 23 (2) 302-13
23. Khersonsky, O.; Tawfik, D. S. Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases ChemBioChem 2006, 7 (1) 49-53
24. Harel, M.; Aharoni, A.; Gaidukov, L.; Brumshtein, B.; Khersonsky, O.; Meged, R.; Dvir, H.; Ravelli, R. B.; McCarthy, A.; Toker, L.; Silman, I.; Sussman, J. L.; Tawfik, D. S. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes Nat. Struct. Mol. Biol. 2004, 11 (5) 412-9
25. Gan, K. N.; Smolen, A.; Eckerson, H. W.; La Du, B. N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities Drug Metab. Dispos. 1991, 19 (1) 100-6
26. Blois, M. S. Antioxidant determination by the use of a stsble free radical Nature 1958, 181, 1199-1200
27. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function J. Comput. Chem. 1998, 19, 1639-1662
28. Goodsell, D. S.; Morris, G. M.; Olson, A. J. Automated docking of flexible ligands: applications of AutoDock J. Mol. Recognit. 1996, 9 (1) 1-5
29. Tavori, H.; Rosenblat, M.; Vaya, J.; Aviram, M. Paraoxonase 1 interactions with atheroscleritic lesions and arterial macrophages protect against foam cell formation and atherosclerosis development Clin. Lipidiol. 2010, 5, 685-697
30. Shpigelman, A.; Israeli, G.; Livney, Y. Thermally-induced protein-polyphenol co-assemblies: beta lactoglobulin-based nanocomplexes as protective nanovehicles for EGCG Food Hydrocolloids 2010, 24, 735-743
31. Ware, J. R.; Baker, R. A.; Sipowicz, R. R. Performance of mental deficients on a simple vigilance task Am. J. Ment. Defic. 1962, 66, 647-50
32. Lakowicz, J. R.; Weber, G. Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules Biochemistry 1973, 12 (21) 4161-70
33. Liang, L.; Tajmir-Riahi, H. A.; Subirade, M. Interaction of beta-lactoglobulin with resveratrol and its biological implications Biomacromolecules 2008, 9 (1) 50-6
34. Lakowicz, J. R. Principles of Fluorescence Spectroscopy, 3 rd ed.; Springer: New York, 2006.
35. Yan, J. H. Studies of interaction between colchicine and bovine serum albumin by fluorescence quenching method J. Mol. Struct. 2005, 750, 174-178
36. Marsillach, J.; Mackness, B.; Mackness, M.; Riu, F.; Beltran, R.; Joven, J.; Camps, J. Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues Free Radical Biol. Med. 2008, 45 (2) 146-57
37. Tavori, H.; Vaya, J.; Aviram, M. Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity Adv. Exp. Med. Biol. 2010, 660, 99-111
38. Babaev, V. R.; Li, L.; Shah, S.; Fazio, S.; Linton, M. F.; May, J. M. Combined vitamin C and vitamin E deficiency worsens early atherosclerosis in apolipoprotein E-deficient mice Arterioscler., Thromb., Vasc. Biol. 2010, 30 (9) 1751-7
39. de Nigris, F.; Williams-Ignarro, S.; Sica, V.; Lerman, L. O.; D'Armiento, F. P.; Byrns, R. E.; Casamassimi, A.; Carpentiero, D.; Schiano, C.; Sumi, D.; Fiorito, C.; Ignarro, L. J.; Napoli, C. Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis Cardiovasc. Res. 2007, 73 (2) 414-23
40. Fuhrman, B.; Buch, S.; Vaya, J.; Belinky, P. A.; Coleman, R.; Hayek, T.; Aviram, M. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice Am. J. Clin. Nutr. 1997, 66 (2) 267-75
41. Rasoulzadeh, F.; Jabary, H. N.; Naseri, A.; Rashidi, M. R. Fluorescence quenching study of quercetin interaction with bovine milk xanthine oxidase Spectrochim. Acta, A 2009, 72 (1) 190-3
42. Tohomas, S.; Willard, W. H.; K., T. A. Human and bovine xanthine oxidases inhibition studies with oxipurinol Biochem. Pharmacol. 1986, 35, 3109-3114
43. Manderson, G. A.; Hardman, M. J.; Creamer, L. K. Effect of heat treatment on bovine beta-lactoglobulin A, B, and C explored using thiol availability and fluorescence J. Agric. Food Chem. 1999, 47 (9) 3617-27